Lab News and Updates
🎉 Lab Website Launch
The Sharma Lab website officially goes live! Showcasing our research in radiopharmaceutical development, team achievements, and latest publications. Welcome to our digital home for cancer theranostics innovation.
🌟 SNMMI Rising Star Recognition
Dr. Sharma recognized as a rising star in nuclear medicine and molecular imaging through SNMMI's prestigious "Ones to Watch" program. This recognition highlights his innovative contributions to the field of molecular imaging.
Read More →📄 New Publication in Theranostics
"An EphA2-targeted alpha particle theranostic for enhancing PDAC treatment" published in Theranostics (2025; 15; 4229-4246). This groundbreaking work demonstrates the potential of alpha particle therapy for pancreatic cancer treatment.
💡 Patent Application Filed
Provisional patent application submitted for "18F-Fluorine incorporation strategy to generate 18F-radiometal theranostic pairs" (JHU Reference: D18426). This innovative technology could revolutionize radiopharmaceutical development.
📄 Nectin-4 PET Research Published
"Nectin-4 PET for optimizing Enfortumab Vedotin dose-response in urothelial carcinoma" published in bioRxiv. This work demonstrates the potential for personalized cancer therapy using PET imaging.
Read Publication →💰 ERF/NETRF Grant Success
$100,000 ERF/NETRF Nuclear Medicine Pilot Research Grant awarded! Dr. Sharma receives funding for "Development of EphA2-Targeted Molecular Radiotheranostics for Lung Neuroendocrine Tumors" (2024-2026).
Read More →🏆 Highest Scored Abstract Award
JHU Radiology Research Day 2023 - Dr. Sharma receives the highest scored abstract award for "Non-Invasive Detection of Multiple Myeloma Using Ga-68 Labelled CD38 Targeting Peptide."
💰 Johns Hopkins Pilot Award
Colorectal Cancer Research Center of Excellence Pilot Award ($50,000) awarded for "Developing Albumin-Bound EphA2-Targeted Molecular Radiotherapeutics for Treatment of Colorectal Cancer."
📄 Advanced Science Publication
"CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET" published in Advanced Science (2024; 11; 2308617). Featured in JHPDA weekly newsletter.
💰 HERA Foundation Grant Success
HERA Ovarian Cancer Foundation Outside-the-Box Grant awarded! Dr. Sharma receives $30,000 funding for "Creation of an EphA2-binding radiotherapeutic for targeting ovarian cancer." Featured on HERA Foundation website.
Read More →📄 Redox Biology Publication
"Intracellular peroxynitrite perturbs redox balance, bioenergetics, and Fe–S cluster homeostasis in Mycobacterium tuberculosis" published in Redox Biology (2024; 75; 103285). Collaborative work on antimycobacterial research.
🎤 AACR Annual Meeting Presentations
Multiple presentations at AACR 2024, San Diego - Dr. Sharma and team present cutting-edge research on CD38 pharmacodynamics in multiple myeloma and nectin-4 PET for urothelial carcinoma therapy optimization.
🏆 AACR Scholar-in-Training Award
Scholar-in-Training Award received at AACR Annual Meeting 2022 for "Imaging pancreatic ductal adenocarcinoma using an EphA2 receptor tyrosine kinase binding 68Ga-labeled peptide radiotracer."
🌟 Postdoctoral Fellow of the Month
Department of Radiology, Johns Hopkins University - Dr. Sharma recognized as Postdoctoral Fellow of the Month for outstanding research contributions and dedication.
🏢 Faculty Appointment
Dr. Sharma appointed as Research Associate (Faculty) at Johns Hopkins School of Medicine, Department of Radiology. Transition from postdoctoral fellow to independent faculty position marks a significant career milestone.
🤝 Professional Society Memberships
New memberships in prestigious scientific societies: Dr. Sharma joins the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and American Chemical Society (ACS), expanding his professional network and collaborative opportunities.
Upcoming Events & Milestones
AACR Annual Meeting 2025
Dr. Sharma and team will present latest findings on nectin-4 PET for enhancing urothelial carcinoma treatment at the American Association for Cancer Research Annual Meeting in Chicago, IL.
SNMMI Annual Meeting
Multiple abstracts submitted showcasing our latest work in radiopharmaceutical development and molecular imaging applications.
World Molecular Imaging Congress
Dr. Sharma serving as abstract reviewer for WMIC 2025, contributing to the advancement of molecular imaging research globally.
Media Highlights
- November 2024: Featured in NETRF blog for receiving ERF/NETRF Nuclear Medicine Research Grant
- March 2024: HERA Foundation website highlight for Outside-the-Box grant award
- March 2024: JHPDA weekly newsletter coverage of HERA grant and Advanced Science publication